METAP1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.17277323805365E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.60249999994855E-06 |
Normal-vs-Stage2 |
4.637200E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.041000E-03 |
Stage1-vs-Stage2 |
6.667800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.230200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
9.216000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.35349961741349E-10 |
Normal-vs-AfricanAmerican |
3.536800E-01 |
Normal-vs-Asian |
2.855900E-02 |
Caucasian-vs-AfricanAmerican |
5.709000E-01 |
Caucasian-vs-Asian |
9.029800E-01 |
AfricanAmerican-vs-Asian |
7.472800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.01089999998894E-06 |
Normal-vs-Female |
3.33170000033078E-07 |
Male-vs-Female |
4.690600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.399990E-03 |
Normal-vs-Extreme_Weight |
5.86689999999557E-05 |
Normal-vs-Obese |
3.185100E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
4.137800E-01 |
Normal_Weight-vs-Obese |
2.274800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.054400E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.663000E-01 |
Normal-vs-Age(41-60Yrs) |
2.841900E-04 |
Normal-vs-Age(61-80Yrs) |
5.13090000486827E-08 |
Normal-vs-Age(81-100Yrs) |
4.653800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.316800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.680400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.787600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.840200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.544800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.370200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.687800E-01 |
Normal-vs-Grade 3 |
3.101800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.923400E-01 |
Grade 2-vs-Grade 4 |
2.687800E-01 |
Grade 3-vs-Grade 4 |
3.101800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.44849999667218E-08 |
Normal-vs-N1 |
1.415560E-02 |
N0-vs-N1 |
5.477800E-01 |
|
|